| 摘要 |
<p>A compound having Formula I or II (Formula I) or (Formula II), or a pharmaceutically acceptable salt thereof, wherein X, Z, R<SUB>1</SUB>, R<SUB>2</SUB>, R<SUB>11</SUB> and R<SUB>12</SUB> are as defined in the specification; pharmaceutical compositions thereof; and methods of use thereof.</p> |
| 申请人 |
EXELIXIS, INC.;KOLTUN, ELENA S.;TSUHAKO, AMY L.;AAY, NAING;BROWN, S. DAVID;CHAN, WAI KI VICKY;DU, HONGWANG;HUANG, PING;KANE, BRIAN;KEARNEY, PATRICK;KIM, MOON HWAN;PACK, MICHAEL;XU, WEI;ZHOU, PEIWEN |
发明人 |
KOLTUN, ELENA S.;TSUHAKO, AMY L.;AAY, NAING;BROWN, S. DAVID;CHAN, WAI KI VICKY;DU, HONGWANG;HUANG, PING;KANE, BRIAN;KEARNEY, PATRICK;KIM, MOON HWAN;PACK, MICHAEL;XU, WEI;ZHOU, PEIWEN |
